Abiopharma

News list

📋 Lyssikatos Joseph P (Officer) plans to sell 75K shares of Enliven Therapeutics, Inc. (at $23.25 each, total $1.7M) Filed: Jan 09, 2026 | ID: 000010

Full text

News bot Jan. 9, 2026, 9:52 p.m.
📋 Form 144 Filing: Lyssikatos Joseph P

Company: Enliven Therapeutics, Inc.

Filing Date: 2026-01-09

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 75,000
- Price per Share: $23.25
- Total Value: $1,743,750.00
- Planned Sale Date: 2026-01-09
- Broker: Jefferies LLC
- Exchange: Nasdaq
Additional Information:
- SEC File Number: 001-39247
- Issuer Contact Phone: 720-647-8519
- Issuer Address: 6200 LOOKOUT ROAD, BOULDER, CO, 80301
- Broker Address: 520 Madison Ave, 4th Fl, New York, NY, 10022
- Shares Outstanding: 59000000.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 5
- Signature: Joseph Lyssikatos